Literature DB >> 20106617

Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level.

Caroline Hachon1, Stéphanie Iannuzzi, Yves Chaix.   

Abstract

Neurofibromatosis type 1 (NF1) is one of the most frequent monogenetic disorder encountered in children. Approximately 50% of children with NF1 develop learning disabilities notably for reading. Understanding the reasons of reading impairment in this context may lead to improve therapeutic methods in NF1 and more generally in reading developmental disorders. An interesting challenge is to disentangle the connections between the different levels of description proposed in the etiological approach. This is the aim of this review based on recent advances in analysis of cognitive deficits observed in children with NF1 and on results of recent brain imaging (structural and functional) or animal model studies.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20106617     DOI: 10.1016/j.braindev.2009.12.008

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  11 in total

1.  Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.

Authors:  Ivayla Apostolova; Dagmara Niedzielska; Thorsten Derlin; Eva J Koziolek; Holger Amthauer; Benedikt Salmen; Jens Pahnke; Winfried Brenner; Victor F Mautner; Ralph Buchert
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-18       Impact factor: 6.200

2.  Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.

Authors:  Marco Carotenuto; Maria Esposito
Journal:  Neurol Sci       Date:  2013-03-27       Impact factor: 3.307

3.  Neurofibromatosis without Neurofibromas: Confirmation of a Genotype-Phenotype Correlation and Implications for Genetic Testing.

Authors:  B Quintáns; J Pardo; B Campos; F Barros; V Volpini; A Carracedo; M J Sobrido
Journal:  Case Rep Neurol       Date:  2011-04-11

4.  Pediatric neurofibromatosis 1 and parental stress: a multicenter study.

Authors:  Maria Esposito; Rosa Marotta; Michele Roccella; Beatrice Gallai; Lucia Parisi; Serena Marianna Lavano; Marco Carotenuto
Journal:  Neuropsychiatr Dis Treat       Date:  2014-01-22       Impact factor: 2.570

Review 5.  Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome.

Authors:  Carl E Stafstrom; Verena Staedtke; Anne M Comi
Journal:  Front Neurol       Date:  2017-03-17       Impact factor: 4.003

6.  Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).

Authors:  S Eijk; S E Mous; G C Dieleman; B Dierckx; A B Rietman; P F A de Nijs; L W Ten Hoopen; R van Minkelen; Y Elgersma; C E Catsman-Berrevoets; R Oostenbrink; J S Legerstee
Journal:  J Autism Dev Disord       Date:  2018-07

7.  Visuoperceptual Impairment in Children with NF1: From Early Visual Processing to Procedural Strategies.

Authors:  Sara Bulgheroni; Matilde Taddei; Veronica Saletti; Silvia Esposito; Roberto Micheli; Daria Riva
Journal:  Behav Neurol       Date:  2019-01-13       Impact factor: 3.342

8.  Sporadic and Familial Variants in NF1: An Explanation of the Wide Variability in Neurocognitive Phenotype?

Authors:  Maëlle Biotteau; Sébastien Déjean; Sandrine Lelong; Stéphanie Iannuzzi; Nathalie Faure-Marie; Pierre Castelnau; François Rivier; Valérie Lauwers-Cancès; Eloïse Baudou; Yves Chaix
Journal:  Front Neurol       Date:  2020-05-05       Impact factor: 4.003

9.  COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.

Authors:  Danielle de Souza Costa; Jonas J de Paula; Antonio M Alvim-Soares; Patrícia A Pereira; Leandro F Malloy-Diniz; Luiz O C Rodrigues; Marco A Romano-Silva; Débora M de Miranda
Journal:  Front Hum Neurosci       Date:  2016-07-05       Impact factor: 3.169

10.  Clinical characterization of children and adolescents with NF1 microdeletions.

Authors:  Hildegard Kehrer-Sawatzki; Lan Kluwe; Johannes Salamon; Lennart Well; Said Farschtschi; Thorsten Rosenbaum; Victor-Felix Mautner
Journal:  Childs Nerv Syst       Date:  2020-06-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.